We work with clients to use intellectual property data and analytics to make better decisions while improving their IP Strategy. We help clients to use IP information to:
Insights about using information and data to inform your IP Strategy
Most boards plan around a single date. The patent expires, competitors arrive, the revenue line falls off a ledge. That model is tidy, it sits in the forecast, and for high-value products it is usually wrong. A recent analysis on DrugPatentWatch works through the loss-of-exclusivity…
When a market is about to triple in a decade, the patent filing map you drew for yesterday’s demand is the one that will let you down. A McKinsey analysis, written with the Indian Electrical and Electronics Manufacturers Association, puts numbers on the shift: India’s…
The most expensive failures in R&D are not the projects that fail. They are the projects that should never have started — and the ones that limp along because nobody had the evidence to kill them early. Patsnap’s 2026 R&D Benchmark Report puts numbers on…
July was a month about ownership. Not compliance, not litigation skill – ownership. Google’s edge sits on TPU technology that competitors must come back and license. Sanofi lost the mRNA product race and is now taxing the winners through delivery patents it happens to hold.…
When Berkshire Hathaway takes a $10 billion stake in Alphabet, the headline is the money. The real story is what Google chose not to monetise on its own. Google’s most valuable asset isn’t its ad engine or its cash pile—it’s the TPU, a proprietary chip…
What happens when intellectual property built into your products turns out to belong to someone else? This week supplied three expensive answers. Each involved one of the world’s most powerful companies paying – or being ordered to pay – for rights held by a much…
